Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ajanta Pharma Q4 Net Up 39.53 Per Cent

This article was originally published in PharmAsia News

Executive Summary

Economic Times of India (05/01/07)

Economic Times of India (05/01/07)

India-based Ajanta Pharma achieved a net profit of RS 7.62 crore on total income of RS 80.09 crore during fiscal fourth quarter ending on March 31, 2007. This quarter is 39.53 better in net profit than last year's fourth quarter. Ajanta's fiscal 2007 post-tax profit rose 32 percent on revenue up 16 percent, compared to the previous year. The Ajanta Pharma board has voted to pay a dividend of 20 percent on equity shares. (Click here for more )

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066245

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel